Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI
Multi-center Longitudinal Clinical Study on the Evolution of Neonatal White Matter Injure to ADHD Based on Multi-modality MRI
1 other identifier
observational
348
1 country
9
Brief Summary
The goal of this bidirectional observational cohort study is to investigate the longitudinal relationship between neonatal white matter injury (WMI) and the subsequent development of attention-deficit/hyperactivity disorder (ADHD), and to identify early MRI-based markers associated with ADHD-related outcomes. The study includes both retrospective and prospective cohorts to dynamically evaluate the evolution of brain injury, brain development, and behavioral outcomes from infancy to childhood. The main questions it aims to answer are: Are neonatal WMI characteristics associated with the subsequent development of ADHD? Which MRI-derived features, including semi-quantitative WMI assessment, microstructural alterations, and structural disconnection patterns, are associated with ADHD-related outcomes? Participants with neonatal WMI will undergo longitudinal clinical, neurodevelopmental, and behavioral follow-up. Researchers will analyze clinical information and MRI findings to characterize WMI evolution and identify imaging markers associated with ADHD risk. Participants will: undergo brain MRI examinations according to clinical protocols; receive standardized neurodevelopmental and behavioral assessments during follow-up; have MRI-derived measures, including semi-quantitative WMI scores, white matter microstructural features, and structural disconnection measures, analyzed to investigate their associations with ADHD-related outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2022
CompletedStudy Start
First participant enrolled
January 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2025
CompletedFirst Posted
Study publicly available on registry
September 23, 2026
CompletedSeptember 23, 2026
December 1, 2022
1.6 years
December 28, 2022
September 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Attention-Deficit/Hyperactivity Disorder (ADHD) Diagnosis
ADHD diagnosis will be determined according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, combined with standardized behavioral assessment using the Swanson, Nolan, and Pelham (SNAP) questionnaire. The number of participants meeting the diagnostic criteria for ADHD at follow-up will be recorded.
At 3-5 years of age
Secondary Outcomes (2)
Cognitive Developmental Outcome
During infancy follow-up assessments (6 months to 5 years of age)
Motor Developmental Outcome
During infancy follow-up assessments (6 months to 5 years of age)
Study Arms (2)
White matter injure group
Neonates presented with punctate, linear, or clustered white matter lesions at the center of the semiovale and lateral ventricles, with TIWI hyper-intensive s and with or without T2WI hypointensity.
Control group
No abnormal signals are found on both conventional and diffusion images. SWI and ASL are also considered when necessary.
Eligibility Criteria
The study population is derived from a multicenter neonatal and infant clinical and multimodal MRI database established through a national research project. The database includes clinical information and multimodal MRI data collected from multiple clinical centers. This bidirectional observational cohort study includes neonates with white matter injury (WMI) identified on brain MRI and control neonates without apparent abnormalities on routine MRI. Eligible participants will be screened from the existing database, and clinical characteristics, MRI findings, and longitudinal neurobehavioral outcomes will be analyzed to investigate the association between neonatal brain injury patterns and later developmental outcomes.
You may qualify if:
- Neonates diagnosed with white matter injury (WMI) or neonates without obvious abnormalities on routine MRI examination from the multicenter database.
- Brain MRI examination performed within 28 days after birth, with gestational age ≤42 weeks at examination.
- Complete MRI data available, including T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and diffusion tensor imaging (DTI).
- Complete maternal and pregnancy history information, neonatal demographic characteristics, and clinical information available.
You may not qualify if:
- Congenital nervous system developmental malformations or suspected genetic or metabolic diseases.
- Obvious MRI artifacts affecting image evaluation.
- Inability to complete follow-up neurobehavioral assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Hangzhou, China
Gansu Province Maternity and Child Health Hospital
Lanzhou, China
Qinghai Red Cross Hospital
Qinghai, China
Hebei Children's Hospital
Shijiazhuang, China
Children's Hospital of Soochow University
Suzhou, China
Wuxi Children's Hospital
Wuxi, China
Northwest Women's and Children's Hospital
Xi'an, China
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
Xianyang, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jian Yang, Ph.D.,M.D.
First Affiliated Hospital Xi'an Jiaotong University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 28, 2022
First Posted
September 23, 2026
Study Start
January 29, 2023
Primary Completion
August 23, 2024
Study Completion
May 30, 2025
Last Updated
September 23, 2026
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share